标题
Natural product and natural product derived drugs in clinical trials
作者
关键词
-
出版物
NATURAL PRODUCT REPORTS
Volume 31, Issue 11, Pages 1612-1661
出版商
Royal Society of Chemistry (RSC)
发表日期
2014-09-10
DOI
10.1039/c4np00064a
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Enhanced Lactone Stability of CZ48 in Blood Correlates to its Lack of Toxicity in Mice
- (2016) Xing Liu et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108
- (2015) Karoly Szepeshazi et al. Oncotarget
- Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy
- (2014) Ravi V. J. Chari et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- PM060184, a new tubulin binding agent with potent antitumor activity including P-glycoprotein over-expressing tumors
- (2014) Marta Martínez-Díez et al. BIOCHEMICAL PHARMACOLOGY
- Folate–Vinca Alkaloid Conjugates for Cancer Therapy: A Structure–Activity Relationship
- (2014) Christopher P. Leamon et al. BIOCONJUGATE CHEMISTRY
- Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors
- (2014) S Bauer et al. BRITISH JOURNAL OF CANCER
- Phase II clinical trial of PM00104 (Zalypsis®) in urothelial carcinoma patients progressing after first-line platinum-based regimen
- (2014) Daniel E. Castellano et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Canagliflozin
- (2014) Yuliana Toderika et al. Cardiology in Review
- Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: An update
- (2014) Alessandro Lupi et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Omacetaxine: A Protein Translation Inhibitor for Treatment of Chronic Myelogenous Leukemia
- (2014) V. Gandhi et al. CLINICAL CANCER RESEARCH
- Pharmacokinetic and Pharmacodynamic Profile of Empagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor
- (2014) André J. Scheen CLINICAL PHARMACOKINETICS
- Essential Structure of the κ Opioid Receptor Agonist Nalfurafine for Binding to the κ Receptor
- (2014) Hiroshi Nagase et al. CURRENT PHARMACEUTICAL DESIGN
- Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes
- (2014) Elizabeth M Lamos et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Novel antifungal agents: a patent review (2011 – present)
- (2014) María Victoria Castelli et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Coenzyme Q10 as a therapy for mitochondrial disease
- (2014) I.P. Hargreaves INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Efficacy and Safety of AEZS-108 (LHRH Agonist Linked to Doxorubicin) in Women With Advanced or Recurrent Endometrial Cancer Expressing LHRH Receptors
- (2014) Günter Emons et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Design, Synthesis, and Biological Evaluation of Potent Dual Agonists of Nuclear and Membrane Bile Acid Receptors
- (2014) Claudio D’Amore et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study
- (2014) B. Ascher et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
- (2014) Carlos Galmarini et al. Marine Drugs
- Marine-Sourced Anti-Cancer and Cancer Pain Control Agents in Clinical and Late Preclinical Development
- (2014) David Newman et al. Marine Drugs
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- 2013 FDA drug approvals
- (2014) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- SGLT2-INHIBITORS: A NOVEL CLASS FOR THE TREATMENT OF TYPE 2 DIABETES INTRODUCTION OF SGLT2-INHIBITORS IN CLINICAL PRACTICE
- (2014) J Cuypers et al. ACTA CLINICA BELGICA
- New Interfacial Microtubule Inhibitors of Marine Origin, PM050489/PM060184, with Potent Antitumor Activity and a Distinct Mechanism
- (2013) Benet Pera et al. ACS Chemical Biology
- GSK3 Alpha and Beta Are New Functionally Relevant Targets of Tivantinib in Lung Cancer Cells
- (2013) Lily L. Remsing Rix et al. ACS Chemical Biology
- Resveratrol in the management of human cancer: how strong is the clinical evidence?
- (2013) Andreas Gescher et al. Annals of the New York Academy of Sciences
- Phase II Clinical Study of BC-3781, a Pleuromutilin Antibiotic, in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections
- (2013) W. T. Prince et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Ceftaroline-Avibactam against Gram-Negative and Gram-Positive Pathogens Isolated from Patients in Canadian Hospitals from 2010 to 2012: Results from the CANWARD Surveillance Study
- (2013) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Penetration of GSK1322322 into Epithelial Lining Fluid and Alveolar Macrophages as Determined by Bronchoalveolar Lavage
- (2013) Odin J. Naderer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- N-Chloramines, a Promising Class of Well-Tolerated Topical Anti-Infectives
- (2013) Waldemar Gottardi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Potent Sub-MIC Effect of GSK1322322 and Other Peptide Deformylase Inhibitors onIn VitroGrowth of Staphylococcus aureus
- (2013) Deborah Butler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Enfumafungin Derivative MK-3118 Shows IncreasedIn VitroPotency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates
- (2013) Cristina Jiménez-Ortigosa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of the Pleuromutilin Antibiotic BC-3781 against Bacterial Pathogens Isolated in the SENTRY Antimicrobial Surveillance Program in 2010
- (2013) Susanne Paukner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Solithromycin Inhibition of Protein Synthesis and Ribosome Biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae
- (2013) Ward Rodgers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoAntibacterial Activities of Omadacycline, a Novel Aminomethylcycline
- (2013) A. B. Macone et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Action of the Novel Aminomethylcycline Antibiotic Omadacycline
- (2013) Michael P. Draper et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Natural products: A continuing source of novel drug leads
- (2013) Gordon M. Cragg et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Second generation S1P pathway modulators: Research strategies and clinical developments
- (2013) Marc Bigaud et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Cyclin-Dependent Kinase Modulators and Cancer Therapy
- (2013) Marialucia Gallorini et al. BIODRUGS
- Curcumin in various cancers
- (2013) Adeeb Shehzad et al. BIOFACTORS
- Cyclophilin inhibitors as antiviral agents
- (2013) Michael Peel et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drug
- (2013) J. M. Rowe et al. BLOOD
- SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
- (2013) M. S. Kung Sutherland et al. BLOOD
- A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours
- (2013) D W Bowles et al. BRITISH JOURNAL OF CANCER
- Phase I–II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma
- (2013) R Plummer et al. BRITISH JOURNAL OF CANCER
- Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study
- (2013) B. Rzany et al. BRITISH JOURNAL OF DERMATOLOGY
- Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis
- (2013) Mohamed A. Kharfan-Dabaja et al. BRITISH JOURNAL OF HAEMATOLOGY
- Patient-reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T-DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2-positive locally advanced or metastatic breast cancer
- (2013) Manfred Welslau et al. CANCER
- Tubulin-Targeted Agents Including Docetaxel and Cabazitaxel
- (2013) Philippa Cheetham et al. CANCER JOURNAL
- Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition
- (2013) R. Katayama et al. CANCER RESEARCH
- Osteosarcoma treatment – Where do we stand? A state of the art review
- (2013) Anja Luetke et al. CANCER TREATMENT REVIEWS
- Functions, Therapeutic Applications, and Synthesis of Retinoids and Carotenoids
- (2013) Rosana Álvarez et al. CHEMICAL REVIEWS
- (−)-Cytisine and Derivatives: Synthesis, Reactivity, and Applications
- (2013) Jacques Rouden et al. CHEMICAL REVIEWS
- Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval
- (2013) Hagop M. Kantarjian et al. Clinical Lymphoma Myeloma & Leukemia
- Investigational Antimicrobial Agents of 2013
- (2013) M. J. Pucci et al. CLINICAL MICROBIOLOGY REVIEWS
- Structural and functional insights into human vitamin K epoxide reductase and vitamin K epoxide reductase-like1
- (2013) Wade D. Van Horn CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Recent Developments of 2-Substituted Analogs of 1,25(OH)2D3
- (2013) Can-Fei Zhang et al. CURRENT MEDICINAL CHEMISTRY
- Efficient Antibacterial Agents: A Review of the Synthesis, Biological Evaluation and Mechanism of Pleuromutilin Derivatives
- (2013) Ruofeng Shang et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Polymer–drug conjugates: present state of play and future perspectives
- (2013) Xin Pang et al. DRUG DISCOVERY TODAY
- Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
- (2013) George G. Zhanel et al. DRUGS
- Ceftaroline Fosamil: A Review of its Use in the Treatment of Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia
- (2013) James E. Frampton DRUGS
- Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study
- (2013) H. Gelderblom et al. EUROPEAN JOURNAL OF CANCER
- The mechanism of action, pharmacokinetics, and clinical efficacy of carfilzomib for the treatment of multiple myeloma
- (2013) Chiara Pautasso et al. Expert Opinion on Drug Metabolism & Toxicology
- Panobinostat in lymphoid and myeloid malignancies
- (2013) Amit Khot et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Cyclin-dependent kinase inhibitor therapy for hematologic malignancies
- (2013) Prithviraj Bose et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Resistant chronic myeloid leukemia beyond tyrosine-kinase inhibitor therapy: which role for omacetaxine?
- (2013) Giuseppe Visani et al. EXPERT OPINION ON PHARMACOTHERAPY
- Transient receptor potential vanilloid 1 as a therapeutic target in analgesia
- (2013) János Szolcsányi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Tivantinib: a new promising mesenchymal–epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma
- (2013) Lorenza Rimassa et al. Future Oncology
- Modeling viral kinetics and treatment outcome during alisporivir interferon-free treatment in hepatitis C virus genotype 2 and 3 patients
- (2013) Jeremie Guedj et al. HEPATOLOGY
- Efficacy and Safety of Crofelemer for Noninfectious Diarrhea in HIV-Seropositive Individuals (ADVENT Trial): A Randomized, Double-Blind, Placebo-Controlled, Two-Stage Study
- (2013) Rodger D. MacArthur et al. HIV CLINICAL TRIALS
- In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens
- (2013) Michael Hornsey et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types
- (2013) David J. Farrell et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparison ofin vitroandin vivobiological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104)
- (2013) Michela Romano et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy of NVC-422 in the treatment of dermatophytosis caused byTrichophyton mentagrophytesusing a guinea pig model
- (2013) Mahmoud A. Ghannoum et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Antibiotics in the clinical pipeline in 2013
- (2013) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- New and Emerging Drug Molecules Against Obesity
- (2013) Melvin George et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats
- (2013) Camilla F. Wenceslau et al. JOURNAL OF HYPERTENSION
- Targeting PKC in Human T Cells Using Sotrastaurin (AEB071) Preserves Regulatory T Cells and Prevents IL-17 Production
- (2013) Xuehui He et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Comparative Antimalarial Activities and ADME Profiles of Ozonides (1,2,4-trioxolanes) OZ277, OZ439, and Their 1,2-Dioxolane, 1,2,4-Trioxane, and 1,2,4,5-Tetraoxane Isosteres
- (2013) Xiaofang Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Soy isoflavones and prostate cancer: A review of molecular mechanisms
- (2013) Abeer M. Mahmoud et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Isolation and First Total Synthesis of PM050489 and PM060184, Two New Marine Anticancer Compounds
- (2013) María Jesús Martín et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Ion Mobility Spectrometry Reveals the Mechanism of Amyloid Formation of Aβ(25–35) and Its Modulation by Inhibitors at the Molecular Level: Epigallocatechin Gallate and Scyllo-inositol
- (2013) Christian Bleiholder et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3
- (2013) E. B. Tapper et al. JOURNAL OF VIRAL HEPATITIS
- Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines
- (2013) Nitesh Shirsath et al. LUNG CANCER
- A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma
- (2013) Anna K. Nowak et al. LUNG CANCER
- Antibodies to watch in 2014
- (2013) Janice M Reichert mAbs
- Studies on the Mechanism of Telavancin Decreased Susceptibility in a Laboratory-Derived Mutant
- (2013) Yang Song et al. Microbial Drug Resistance
- Cabazitaxel: A Novel Drug for Hormone-Refractory Prostate Cancer
- (2013) Manav Malhotra et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- From micrograms to grams: scale-up synthesis of eribulin mesylate
- (2013) Melvin J. Yu et al. NATURAL PRODUCT REPORTS
- The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics
- (2013) Hans-Peter Gerber et al. NATURAL PRODUCT REPORTS
- From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes
- (2013) Kyung Bo Kim et al. NATURAL PRODUCT REPORTS
- Industrial natural product chemistry for drug discovery and development
- (2013) Armin Bauer et al. NATURAL PRODUCT REPORTS
- Opioid receptor blocker shows promise in Phase II depression trial
- (2013) Charlotte Harrison NATURE REVIEWS DRUG DISCOVERY
- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
- (2013) Gregory T. Kunkel et al. NATURE REVIEWS DRUG DISCOVERY
- A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation
- (2013) Lynn Webster et al. PAIN
- Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments
- (2013) P.M. Anderson et al. PEDIATRIC BLOOD & CANCER
- Marine natural products: Bryostatins in preclinical and clinical studies
- (2013) Peter Kollár et al. PHARMACEUTICAL BIOLOGY
- Preclinical and Phase I Results of Decitabine in Combination with Midostaurin (PKC412) for Newly Diagnosed Elderly or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia
- (2013) Casey B. Williams et al. PHARMACOTHERAPY
- The Synthetic Amphipathic Peptidomimetic LTX109 Is a Potent Fungicide That Disturbs Plasma Membrane Integrity in a Sphingolipid Dependent Manner
- (2013) Rasmus Bojsen et al. PLoS One
- Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Drug-Eluting Stents: A Meta-Analysis
- (2013) Yicong Ye et al. PLoS One
- Minnelide: A Novel Therapeutic That Promotes Apoptosis in Non-Small Cell Lung Carcinoma In Vivo
- (2013) Ilona Rousalova et al. PLoS One
- Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator
- (2013) Shifeng Pan et al. ACS Medicinal Chemistry Letters
- Decline in new drug launches: myth or reality? Retrospective observational study using 30 years of data from the UK
- (2013) Derek J Ward et al. BMJ Open
- Euphorbia peplus:18th-Century Insights on a 21st-Century Therapy
- (2013) Navya S. Nambudiri et al. JAMA Dermatology
- Pharmacotherapy of Pompe disease
- (2013) Giancarlo Parenti et al. Expert Opinion on Orphan Drugs
- SGLT inhibitors in management of diabetes
- (2013) Abd A Tahrani et al. Lancet Diabetes & Endocrinology
- First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus
- (2013) Anita Kapur et al. BMC Pharmacology & Toxicology
- Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
- (2012) Subash C. Gupta et al. AAPS Journal
- Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the Polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01
- (2012) Sharmistha Sinha et al. ACS Chemical Neuroscience
- The role of immune tolerance induction in restoration of the efficacy of ERT in Pompe disease
- (2012) Emanuela Lacaná et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells
- (2012) Kuo-Pao Lai et al. AMERICAN JOURNAL OF PATHOLOGY
- Absolute Configuration of Beer′s Bitter Compounds
- (2012) Jan Urban et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Romidepsin: A Histone Deacetylase Inhibitor for Refractory Cutaneous T-Cell Lymphoma
- (2012) Miryoung Kim et al. ANNALS OF PHARMACOTHERAPY
- Antibody-Drug Conjugates in Cancer Therapy
- (2012) Eric L. Sievers et al. Annual Review of Medicine
- Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity
- (2012) Q. Shi et al. Anti-Cancer Agents in Medicinal Chemistry
- Inadequate Efficacy of a New Formulation of Fosmidomycin-Clindamycin Combination in Mozambican Children Less than Three Years Old with Uncomplicated Plasmodium falciparum Malaria
- (2012) Miguel Lanaspa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Cyclophilin Inhibitor SCY-635 Disrupts Hepatitis C Virus NS5A-Cyclophilin A Complexes
- (2012) Sam Hopkins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of LTX-109, a Synthetic Antimicrobial Peptide, against Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, Daptomycin-Nonsusceptible, and Linezolid-Nonsusceptible Staphylococcus aureus
- (2012) Louis D. Saravolatz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens
- (2012) D. R. Snydman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ComparativeIn VitroActivities of LFF571 against Clostridium difficile and 630 Other Intestinal Strains of Aerobic and Anaerobic Bacteria
- (2012) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Further Insights into the Mode of Action of the Lipoglycopeptide Telavancin through Global Gene Expression Studies
- (2012) Yang Song et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ComparativeEx VivoActivity of Novel Endoperoxides in Multidrug-Resistant Plasmodium falciparum and P. vivax
- (2012) Jutta Marfurt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods
- (2012) M. A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoCharacterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile
- (2012) Carmela T. M. Mascio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections
- (2012) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Action of and Mechanism of Reduced Susceptibility to the Novel Anti-Clostridium difficile Compound LFF571
- (2012) J. A. Leeds et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Randomized, Evaluator-Blind, Phase 2 Study Comparing the Safety and Efficacy of Omadacycline to Those of Linezolid for Treatment of Complicated Skin and Skin Structure Infections
- (2012) Gary J. Noel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
- (2012) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of Ipragliflozin (ASP1941): A novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus
- (2012) Masakazu Imamura et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Fluoride enhances the activity of fungicides that destabilize cell membranes
- (2012) Sanshu Li et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of β-1,3-glucan synthase
- (2012) Brian H. Heasley et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours
- (2012) T A Yap et al. BRITISH JOURNAL OF CANCER
- Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial
- (2012) J Cummings et al. BRITISH JOURNAL OF CANCER
- First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials
- (2012) Joerg J. Moehrle et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer
- (2012) Sandhya Girish et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Antibody-Drug Conjugates for the Treatment of Cancer
- (2012) John A. Flygare et al. Chemical Biology & Drug Design
- Stress Degradation Studies of Tebipenem and a Validated Stability-Indicating LC Method
- (2012) Judyta Cielecka-Piontek et al. CHROMATOGRAPHIA
- Anti-Myeloma Effects of the Novel Anthracycline Derivative INNO-206
- (2012) E. Sanchez et al. CLINICAL CANCER RESEARCH
- -H2AX Foci Formation as a Pharmacodynamic Marker of DNA Damage Produced by DNA Cross-Linking Agents: Results from 2 Phase I Clinical Trials of SJG-136 (SG2000)
- (2012) J. Wu et al. CLINICAL CANCER RESEARCH
- Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer
- (2012) A. Vidal et al. CLINICAL CANCER RESEARCH
- Carfilzomib and ONX 0912 Inhibit Cell Survival and Tumor Growth of Head and Neck Cancer and Their Activities Are Enhanced by Suppression of Mcl-1 or Autophagy
- (2012) Y. Zang et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer
- (2012) P. Nathan et al. CLINICAL CANCER RESEARCH
- Phase I Clinical and Pharmacokinetic Evaluation of the Vascular-Disrupting Agent OXi4503 in Patients with Advanced Solid Tumors
- (2012) Dan M. Patterson et al. CLINICAL CANCER RESEARCH
- Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA Synthesis
- (2012) Irina Artsimovitch et al. CLINICAL INFECTIOUS DISEASES
- LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial
- (2012) B Zambrowicz et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Eribulin Mesylate (E7389): Review of Efficacy and Tolerability in Breast, Pancreatic, Head and Neck, and Non–Small Cell Lung Cancer
- (2012) Sarah L. Scarpace CLINICAL THERAPEUTICS
- The Chemistry and Biology of the Bryostatins: Potential PKC Inhibitors in Clinical Development
- (2012) B.-F. Ruan et al. CURRENT MEDICINAL CHEMISTRY
- Molecular Targets of FTY720 (Fingolimod)
- (2012) M.R. Pitman et al. CURRENT MOLECULAR MEDICINE
- New horizons for host defense peptides and lantibiotics
- (2012) Michael John Dawson et al. CURRENT OPINION IN PHARMACOLOGY
- Targeting mTOR Pathways in Human Malignancies
- (2012) Angelica Fasolo et al. CURRENT PHARMACEUTICAL DESIGN
- Expanding medicinal chemistry space
- (2012) Andy Barker et al. DRUG DISCOVERY TODAY
- The use of sinecatechins (polyphenon E) ointment for treatment of external genital warts
- (2012) Eggert Stockfleth et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- AEZS-108: a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors
- (2012) Joerg Engel et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Update on alisporivir in treatment of viral hepatitis C
- (2012) Robert Flisiak et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- EC145: a novel targeted agent for adenocarcinoma of the lung
- (2012) Pamela Pribble et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
- (2012) George G Zhanel et al. Expert Review of Anti-Infective Therapy
- PKCθ: a new target for selective immunosuppression
- (2012) Amnon Altman et al. Expert Review of Clinical Immunology
- Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis
- (2012) Kenji Chiba et al. Future Medicinal Chemistry
- Differences in drug approval processes of 3 regulatory agencies: a case study of gemtuzumab ozogamicin
- (2012) Tetsuya Tanimoto et al. INVESTIGATIONAL NEW DRUGS
- Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection
- (2012) G. S. Crowther et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)
- (2012) M. A. Pfaller et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)
- (2012) H. S. Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Quantitative determination of the anticancer prodrug combretastatin A1 phosphate (OXi4503, CA1P), the active CA1 and its glucuronide metabolites in human urine and of CA1 in plasma by HPLC with mass spectrometric detection
- (2012) Michael R.L. Stratford et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Development and validation of a rapid and sensitive liquid chromatography–tandem mass spectrometry method for benvitimod quantification in human plasma
- (2012) Libo Zhao et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection
- (2012) Sam Hopkins et al. JOURNAL OF HEPATOLOGY
- Discovery of LFF571: An Investigational Agent for Clostridium difficile Infection
- (2012) Matthew J. LaMarche et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Tofogliflozin, a Novel C-Arylglucoside with an O-Spiroketal Ring System, as a Highly Selective Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes
- (2012) Yoshihito Ohtake et al. JOURNAL OF MEDICINAL CHEMISTRY
- Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
- (2012) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Natural Products As Sources for New Pesticides
- (2012) Charles L. Cantrell et al. JOURNAL OF NATURAL PRODUCTS
- A phase II trial of oral gimatecan for recurrent glioblastoma
- (2012) Jethro Hu et al. JOURNAL OF NEURO-ONCOLOGY
- Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: Results from a 12-week, open-label pilot study in multiple sclerosis patients
- (2012) James B. Moberly et al. JOURNAL OF NEUROIMMUNOLOGY
- Bacterial Biosynthesis and Maturation of the Didemnin Anti-cancer Agents
- (2012) Ying Xu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- FDA rejects novel diabetes drug over safety fears
- (2012) Talha Khan Burki LANCET
- Brentuximab vedotin
- (2012) Niels W. C.J. van de Donk et al. mAbs
- Tetrodotoxin (TTX) as a Therapeutic Agent for Pain
- (2012) Francisco Rafael Nieto et al. Marine Drugs
- TPI-287, a New Taxane Family Member, Reduces the Brain Metastatic Colonization of Breast Cancer Cells
- (2012) D. P. Fitzgerald et al. MOLECULAR CANCER THERAPEUTICS
- Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice
- (2012) Elfrida R Benjamin et al. MOLECULAR THERAPY
- Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors
- (2012) Edwin G. Pérez et al. NATURAL PRODUCT REPORTS
- Triptolide: structural modifications, structure–activity relationships, bioactivities, clinical development and mechanisms
- (2012) Zhao-Li Zhou et al. NATURAL PRODUCT REPORTS
- From natural product to marketed drug: the tiacumicin odyssey
- (2012) William Erb et al. NATURAL PRODUCT REPORTS
- Brentuximab vedotin
- (2012) Anas Younes et al. NATURE REVIEWS DRUG DISCOVERY
- Ingenol Mebutate Gel for Actinic Keratosis
- (2012) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- The European Medicines Agency Review of Cabazitaxel (Jevtana(R)) for the Treatment of Hormone-Refractory Metastatic Prostate Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
- (2012) E. Pean et al. ONCOLOGIST
- A study of the bacterial community in the root system of the maytansine containing plant Putterlickia verrucosa
- (2012) Susanne Wings et al. PHYTOCHEMISTRY
- Efficacy and Safety of Telavancin in Clinical Trials: A Systematic Review and Meta-Analysis
- (2012) Konstantinos A. Polyzos et al. PLoS One
- The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease
- (2012) Richie Khanna et al. PLoS One
- Pan-Bcl-2 Inhibitor AT-101 Enhances Tumor Cell Killing by EGFR Targeted T Cells
- (2012) Archana Thakur et al. PLoS One
- N-Chlorotaurine, a Long-Lived Oxidant Produced by Human Leukocytes, Inactivates Shiga Toxin of Enterohemorrhagic Escherichia coli
- (2012) Christian Eitzinger et al. PLoS One
- Pharmacological chaperone therapy for Fabry disease
- (2012) Satoshi ISHII PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Current drug research on PEGylation with small molecular agents
- (2012) Wenjun Li et al. PROGRESS IN POLYMER SCIENCE
- A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer
- (2012) R. Chugh et al. Science Translational Medicine
- The molecular mystique of tetrodotoxin
- (2012) Edward G. Moczydlowski TOXICON
- On the importance of synthetic organic chemistry in drug discovery: reflections on the discovery of antidiabetic agent ertugliflozin
- (2012) Vincent Mascitti et al. MedChemComm
- Methylnaltrexone for the treatment of opioid-induced constipation
- (2012) Sabine Bader et al. Expert Review of Gastroenterology & Hepatology
- The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites
- (2012) Michael Delves et al. PLOS MEDICINE
- Structural basis for the cyclophilin A binding affinity and immunosuppressive potency ofE-ISA247 (voclosporin)
- (2011) Andreas Kuglstatter et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Vinflunine
- (2011) Luis Miguel Anton Aparicio et al. ANTI-CANCER DRUGS
- In VitroActivities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species
- (2011) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Second Target of the Antimalarial and Antibacterial Agent Fosmidomycin Revealed by Cellular Metabolic Profiling
- (2011) Baichen Zhang et al. BIOCHEMISTRY
- Design of Antibody−Maytansinoid Conjugates Allows for Efficient Detoxification via Liver Metabolism
- (2011) Xiuxia Sun et al. BIOCONJUGATE CHEMISTRY
- α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging
- (2011) William D. Shrader et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
- (2011) M. Levis et al. BLOOD
- Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial
- (2011) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation
- (2011) D. Rischin et al. CLINICAL CANCER RESEARCH
- Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
- (2011) B. C. Potts et al. CURRENT CANCER DRUG TARGETS
- New Lead Structures in Antifungal Drug Discovery
- (2011) Chunquan Sheng et al. CURRENT MEDICINAL CHEMISTRY
- Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients
- (2011) R. L. Dobbins et al. DIABETES OBESITY & METABOLISM
- Opioid modulators for alcohol dependence
- (2011) Thomas Hillemacher et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Romidepsin: a novel histone deacetylase inhibitor for cancer
- (2011) Erin M Bertino et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Brentuximab Vedotin (SGN-35), an antibody–drug conjugate for the treatment of CD30-positive malignancies
- (2011) Antonio Gualberto EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Preclinical and clinical activity of the topoisomerase I inhibitor, karenitecin, in melanoma
- (2011) Pamela N Munster et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- New β-glucan inhibitors as antifungal drugs
- (2011) Richard F Hector et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Purification and Identification of Activating Enzymes of CS-0777, a Selective Sphingosine 1-Phosphate Receptor 1 Modulator, in Erythrocytes
- (2011) Kiyoaki Yonesu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a Novel Mode of Protein Kinase Inhibition Characterized by the Mechanism of Inhibition of Human Mesenchymal-epithelial Transition Factor (c-Met) Protein Autophosphorylation by ARQ 197
- (2011) Sudharshan Eathiraj et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DA6034 promotes gastric epithelial cell migration and wound-healing through the mTOR pathway
- (2011) Young Woo Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Ingenol Mebutate Field-Directed Treatment of UVB-Damaged Skin Reduces Lesion Formation and Removes Mutant p53 Patches
- (2011) Sarah-Jane Cozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Structural identification of SAR-943 metabolites generated by human liver microsomes in vitro using mass spectrometry in combination with analysis of fragmentation patterns
- (2011) Tobin Strom et al. JOURNAL OF MASS SPECTROMETRY
- Discovery of 7-Hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a Tubulin Polymerization Inhibitor with Potent Antiproliferative and Tumor Vascular Disrupting Properties
- (2011) Bernard L. Flynn et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Synthetic Antimicrobial Peptidomimetic (LTX 109): Stereochemical Impact on Membrane Disruption
- (2011) Johan Isaksson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy
- (2011) Roger B. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent
- (2011) Xiao-Yi Xiao et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Spicamycin Derivative (KRN5500) Provides Neuropathic Pain Relief in Patients With Advanced Cancer: A Placebo-Controlled, Proof-of-Concept Trial
- (2011) Sharon M. Weinstein et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Civamide Cream 0.075% in Patients with Osteoarthritis of the Knee: A 12-Week Randomized Controlled Clinical Trial with a Longterm Extension
- (2011) T. J. SCHNITZER et al. JOURNAL OF RHEUMATOLOGY
- Pyridorin in Type 2 Diabetic Nephropathy
- (2011) E. J. Lewis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer
- (2011) Maria Q. Baggstrom et al. Journal of Thoracic Oncology
- Farnesoid X Receptor Agonist for the Treatment of Liver and Metabolic Disorders: Focus on 6-ethyl-CDCA
- (2011) S. Fiorucci et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Natural products and Pharma 2011: Strategic changes spur new opportunities
- (2011) Guy T. Carter NATURAL PRODUCT REPORTS
- EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats
- (2011) Wenbin Zhang et al. PHARMACOLOGICAL RESEARCH
- Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
- (2011) S. A. Charman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of CS-0777: A Potent, Selective, and Orally Active S1P1 Agonist
- (2011) Takahide Nishi et al. ACS Medicinal Chemistry Letters
- Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma
- (2010) Simon Ekman et al. ACTA ONCOLOGICA
- Molecular Characterization of Off-Target Activities of Telithromycin: a Potential Role for Nicotinic Acetylcholine Receptors
- (2010) D. Bertrand et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Investigation of the Potential for Mutational Resistance to XF-73, Retapamulin, Mupirocin, Fusidic Acid, Daptomycin, and Vancomycin in Methicillin-ResistantStaphylococcus aureusIsolates during a 55-Passage Study
- (2010) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing
- (2010) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli
- (2010) M. G. P. Page et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and Spectrum of the Neoglycoside ACHN-490
- (2010) J. B. Aggen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma
- (2010) D. Chauhan et al. BLOOD
- PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity
- (2010) JFM Leal et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Skin Cancer Chemotherapeutic Agent Ingenol-3-Angelate (PEP005) Is a Substrate for the Epidermal Multidrug Transporter (ABCB1) and Targets Tumor Vasculature
- (2010) Luowei Li et al. CANCER RESEARCH
- Turning Glucosuria into a Therapy: Efficacy and Safety with SGLT2 Inhibitors
- (2010) Anupa K. Patel et al. Current Diabetes Reports
- Bryostatins: biological context and biotechnological prospects
- (2010) Amaro E Trindade-Silva et al. CURRENT OPINION IN BIOTECHNOLOGY
- Combating evolution with intelligent design: the neoglycoside ACHN-490
- (2010) Eliana S Armstrong et al. CURRENT OPINION IN MICROBIOLOGY
- The year's new drugs & biologics - 2008
- (2010) A.I. Graul et al. DRUG NEWS & PERSPECTIVES
- The year's new drugs & biologics - 2009
- (2010) A.I. Graul et al. DRUG NEWS & PERSPECTIVES
- New Lipoglycopeptides
- (2010) George G. Zhanel et al. DRUGS
- The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site
- (2010) Audrey Tupin et al. EMBO JOURNAL
- Current strategies for drug discovery through natural products
- (2010) Alan L Harvey et al. Expert Opinion on Drug Discovery
- Lestaurtinib, a multitargeted tyrosinse kinase inhibitor: from bench to bedside
- (2010) Munira Shabbir et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia
- (2010) Mark Wallace et al. Expert Review of Neurotherapeutics
- In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species
- (2010) David J. Farrell et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy
- (2010) Sang Joon Shin et al. INVESTIGATIONAL NEW DRUGS
- Organization of the biosynthetic genes encoding deoxyactagardine B (DAB), a new lantibiotic produced by Actinoplanes liguriae NCIMB41362
- (2010) Steven Boakes et al. JOURNAL OF ANTIBIOTICS
- Determination of picropodophyllin and its isomer podophyllotoxin in human serum samples with electrospray ionization of hexylamine adducts by liquid chromatography–tandem mass spectrometry
- (2010) Yuko Rönquist-Nii et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
- (2010) Thomas Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery of Canagliflozin, a NovelC-Glucoside with Thiophene Ring, as Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus(1)
- (2010) Sumihiro Nomura et al. JOURNAL OF MEDICINAL CHEMISTRY
- (1S)-1,5-Anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-d-glucitol (TS-071) is a Potent, Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for Type 2 Diabetes Treatment
- (2010) Hiroyuki Kakinuma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Accumulation of 1-deoxynojirimycin in silkworm, Bombyx mori L.
- (2010) Hao Yin et al. Journal of Zhejiang University-SCIENCE B
- Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ
- (2010) Kazuhiro Irie et al. MEDICINAL RESEARCH REVIEWS
- Intestinal Absorption Mechanism of Tebipenem Pivoxil, a Novel Oral Carbapenem: Involvement of Human OATP Family in Apical Membrane Transport
- (2010) Kazuhiko Kato et al. MOLECULAR PHARMACEUTICS
- Vitamin D, disease and therapeutic opportunities
- (2010) Lori A. Plum et al. NATURE REVIEWS DRUG DISCOVERY
- Cabazitaxel
- (2010) Matthew D. Galsky et al. NATURE REVIEWS DRUG DISCOVERY
- SGLT2 inhibition — a novel strategy for diabetes treatment
- (2010) Edward C. Chao et al. NATURE REVIEWS DRUG DISCOVERY
- An insight into the antifungal pipeline: selected new molecules and beyond
- (2010) Luis Ostrosky-Zeichner et al. NATURE REVIEWS DRUG DISCOVERY
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
- (2010) N. Srinivas et al. SCIENCE
- A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study
- (2010) Patrick Serruys et al. EuroIntervention
- Vinflunine: review of a new vinca alkaloid and its potential role in oncology
- (2010) John S Ng JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- De Novo Design of Antimicrobial Polymers, Foldamers, and Small Molecules: From Discovery to Practical Applications
- (2009) Gregory N. Tew et al. ACCOUNTS OF CHEMICAL RESEARCH
- Probing the Antimalarial Mechanism of Artemisinin and OZ277 (Arterolane) with Nonperoxidic Isosteres and Nitroxyl Radicals
- (2009) M. A. Fugi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Virus RNA Replication In Vitro
- (2009) S. Hopkins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Quaternary ammonium N,N-dichloroamines as topical, antimicrobial agents
- (2009) Charles Francavilla et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Polyphenon E®: a new treatment for external anogenital warts
- (2009) S. Tatti et al. BRITISH JOURNAL OF DERMATOLOGY
- Antitumor activity and pharmacokinetics of oral gimatecan on pediatric cancer xenografts
- (2009) Massimo Zucchetti et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Crystalline Camptothecin-20(S)-O-Propionate Hydrate:A Novel Anticancer Agent with Strong Activity against 19 Human Tumor Xenografts
- (2009) Z. Cao et al. CANCER RESEARCH
- The First Evaluation of a Novel Vitamin K Antagonist, Tecarfarin (ATI-5923), in Patients With Atrial Fibrillation
- (2009) David J. Ellis et al. CIRCULATION
- CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria
- (2009) Shannon D. Putnam et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Amadacycline
- (2009) Y. Wang et al. DRUGS OF THE FUTURE
- A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P)
- (2009) Dietmar W Siemann et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Brostallicin (PNU-166196), a new minor groove DNA binder: preclinical and clinical activity
- (2009) Domenica Lorusso et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma
- (2009) Paul A Meyers Expert Review of Anticancer Therapy
- Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA)
- (2009) April Barbour et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer
- (2009) Sang Joon Shin et al. INVESTIGATIONAL NEW DRUGS
- XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity
- (2009) N. Ooi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication
- (2009) Udayan Chatterji et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of 3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a Potent and Selective Inhibitor of Protein Kinase C Isotypes
- (2009) Jürgen Wagner et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)
- (2009) Han-Jie Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Pyrrolobenzodiazepine Dimer SJG-136 Forms Sequence-Dependent Intrastrand DNA Cross-Links and Monoalkylated Adducts in Addition to Interstrand Cross-Links
- (2009) Khondaker M. Rahman et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Crofelemer, an Antisecretory Antidiarrheal Proanthocyanidin Oligomer Extracted from Croton lechleri, Targets Two Distinct Intestinal Chloride Channels
- (2009) L. Tradtrantip et al. MOLECULAR PHARMACOLOGY
- Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study
- (2009) H. Kumagai et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Novel mode of action of spinosad: Receptor binding studies demonstrating lack of interaction with known insecticidal target sites
- (2009) Nailah Orr et al. PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY
- A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
- (2009) Michael T Guskey et al. PHARMACOTHERAPY
- De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers
- (2009) S. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal Structures of Biapenem and Tebipenem Complexed with Penicillin-Binding Proteins 2X and 1A from Streptococcus pneumoniae
- (2008) M. Yamada et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and SAR of novel parenteral anti-pseudomonal cephalosporins: Discovery of FR264205
- (2008) Ayako Toda et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks
- (2008) E. M. Ocio et al. BLOOD
- Stability and Stabilization Studies of TAK-599 (Ceftaroline Fosamil), a Novel N-Phosphono Type Prodrug of Anti-methicillin Resistant Staphylococcus aureus Cephalosporin T-91825
- (2008) Yukihiro Ikeda et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- The impact of natural products upon modern drug discovery
- (2008) A Ganesan CURRENT OPINION IN CHEMICAL BIOLOGY
- Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes
- (2008) Wei Meng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity
- (2008) Samuel Chackalamannil et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tetrodotoxin for Moderate to Severe Cancer Pain: A Randomized, Double Blind, Parallel Design Multicenter Study
- (2008) Neil A. Hagen et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Natural products to drugs: natural product-derived compounds in clinical trials
- (2008) Mark S. Butler NATURAL PRODUCT REPORTS
- Characterization of sirolimus metabolites in pediatric solid organ transplant recipients
- (2008) Guido Filler et al. PEDIATRIC TRANSPLANTATION
- N-Chloro-2,2-dimethyltaurines: a new class of remarkably stable N-chlorotaurines
- (2008) Lu Wang et al. TETRAHEDRON LETTERS
- Curcumin as “Curecumin”: From kitchen to clinic
- (2007) Ajay Goel et al. BIOCHEMICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now